Jorn Kekow

Vogelsang, BB, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register.

Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register.

Journal: RMD open

Published: July 11, 2023

Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register.

Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register.

Journal: Annals of the rheumatic diseases

Published: April 25, 2021

Idiopathic Inflammatory Myopathies

Idiopathic Inflammatory Myopathies

Journal: Deutsche medizinische Wochenschrift (1946)

Published: July 03, 2020

Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT.

Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT.

Journal: RMD open

Published: April 26, 2020

Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.

Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.

Journal: Annals of the rheumatic diseases

Published: February 20, 2020

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis.

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: February 20, 2020

Outpatient specialist medical treatment (ASV)-a new treatment level in rheumatology

Outpatient specialist medical treatment (ASV)-a new treatment level in rheumatology

Journal: Zeitschrift fur Rheumatologie

Published: August 29, 2019

Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis.

Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis.

Journal: Seminars in arthritis and rheumatism

Published: May 23, 2019

Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis.

Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: December 23, 2018

Differential Effect of Cobalt and Chromium Ions as Well as CoCr Particles on the Expression of Osteogenic Markers and Osteoblast Function.

Differential Effect of Cobalt and Chromium Ions as Well as CoCr Particles on the Expression of Osteogenic Markers and Osteoblast Function.

Journal: International journal of molecular sciences

Published: September 25, 2018

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity.

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity.

Journal: BMC rheumatology

Published: March 07, 2018

The effects of cobalt and chromium ions on transforming growth factor-beta patterns and mineralization in human osteoblast-like MG63 and SaOs-2 cells.

The effects of cobalt and chromium ions on transforming growth factor-beta patterns and mineralization in human osteoblast-like MG63 and SaOs-2 cells.

Journal: Journal of biomedical materials research. Part A

Published: February 02, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026